MEDFORD, N.J., June 11, 2020 /PRNewswire/ — Pinelands Recovery Center – a regional leader in evidence-based adult treatment of drug and alcohol addiction – has begun COVID-19 testing for all new clients entering its residential treatment facilities, located in Medford, NJ. The testing reinforces the health safety protocols and procedures already in place at the 30-bed center.
Under the new guidelines, each new client at the time of admission meets with a staff registered nurse, who collects a throat swab to determine active infection. The test is sent out to Ammon Labs of Linden, NJ for analysis. Most test results are received within 24 to 48 hours. While awaiting test results, the client is quarantined in a private room to ensure safety of everyone in the facility.
“Providing COVID testing to all new admissions has allowed our clients to safely continue focusing on their treatment goals. It is one of many safeguards we have put into place as we continue to work to provide a calm, therapeutic environment during this time of crisis,” says Christian Losch, program director.
Pinelands Recovery Center, formerly known as Ambrosia Treatment Center, holds the highest accreditation from the Joint Commission, the same level of accreditation and certification as hospitals. However, treatment at Pinelands Recovery Center occurs in a comfortable, estate-style environment instead, located on 44 secluded acres in southern New Jersey.
The center was acquired last year by Discovery Behavioral Health, an expanding nationwide provider of mental health services.